Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-28

Clinical Trial Update: Tranexamic Acid and Spontaneous Chronic Urticaria [Phase 4]

View source ↗

Summary

Phase 4 trial update involving tranexamic acid for chronic spontaneous urticaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Chronic Spontaneous Urticaria | Phase 4 | Status: UNKNOWN